JPH05279236A - Cologne for body - Google Patents
Cologne for bodyInfo
- Publication number
- JPH05279236A JPH05279236A JP10603292A JP10603292A JPH05279236A JP H05279236 A JPH05279236 A JP H05279236A JP 10603292 A JP10603292 A JP 10603292A JP 10603292 A JP10603292 A JP 10603292A JP H05279236 A JPH05279236 A JP H05279236A
- Authority
- JP
- Japan
- Prior art keywords
- ingredient
- oil
- colon
- powder
- poe
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 34
- 239000000843 powder Substances 0.000 claims abstract description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 14
- 150000003839 salts Chemical class 0.000 claims abstract description 11
- 239000004094 surface-active agent Substances 0.000 claims abstract description 10
- 210000001072 colon Anatomy 0.000 claims description 30
- 239000003205 fragrance Substances 0.000 claims description 19
- 239000004909 Moisturizer Substances 0.000 claims description 5
- 230000001333 moisturizer Effects 0.000 claims description 5
- 239000000306 component Substances 0.000 claims 1
- -1 polyoxyethylene Polymers 0.000 abstract description 25
- 239000003921 oil Substances 0.000 abstract description 19
- 239000004615 ingredient Substances 0.000 abstract description 15
- 235000002639 sodium chloride Nutrition 0.000 abstract description 12
- 230000000694 effects Effects 0.000 abstract description 10
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 abstract description 8
- 238000002156 mixing Methods 0.000 abstract description 8
- 229920003171 Poly (ethylene oxide) Polymers 0.000 abstract description 7
- 239000002304 perfume Substances 0.000 abstract description 7
- 239000004359 castor oil Substances 0.000 abstract description 5
- 235000019438 castor oil Nutrition 0.000 abstract description 5
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 abstract description 5
- 239000003974 emollient agent Substances 0.000 abstract description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 abstract description 3
- 229920002545 silicone oil Polymers 0.000 abstract description 3
- 239000004677 Nylon Substances 0.000 abstract description 2
- 239000003906 humectant Substances 0.000 abstract description 2
- 229920001778 nylon Polymers 0.000 abstract description 2
- 239000011780 sodium chloride Substances 0.000 abstract description 2
- 235000019198 oils Nutrition 0.000 description 16
- 229920000858 Cyclodextrin Polymers 0.000 description 8
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 7
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 6
- 235000014113 dietary fatty acids Nutrition 0.000 description 5
- 239000000194 fatty acid Substances 0.000 description 5
- 229930195729 fatty acid Natural products 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 239000008213 purified water Substances 0.000 description 5
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 4
- 229940058015 1,3-butylene glycol Drugs 0.000 description 3
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 3
- 229920001214 Polysorbate 60 Polymers 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- LDDUCKDUDZVHLN-UHFFFAOYSA-N [2-hydroxy-3-[2-hydroxy-3-(16-methylheptadecanoyloxy)propoxy]propyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(O)COCC(O)COC(=O)CCCCCCCCCCCCCCC(C)C LDDUCKDUDZVHLN-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 125000003158 alcohol group Chemical group 0.000 description 3
- 235000019437 butane-1,3-diol Nutrition 0.000 description 3
- 239000006185 dispersion Substances 0.000 description 3
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- 229920001296 polysiloxane Polymers 0.000 description 3
- 230000035807 sensation Effects 0.000 description 3
- 235000019615 sensations Nutrition 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 2
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 2
- 239000000263 2,3-dihydroxypropyl (Z)-octadec-9-enoate Substances 0.000 description 2
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 2
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 2
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical compound CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 238000013329 compounding Methods 0.000 description 2
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical class OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 2
- 230000002500 effect on skin Effects 0.000 description 2
- 229960005309 estradiol Drugs 0.000 description 2
- 229930182833 estradiol Natural products 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 229940075507 glyceryl monostearate Drugs 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 150000002430 hydrocarbons Chemical class 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000010445 mica Substances 0.000 description 2
- 229910052618 mica group Inorganic materials 0.000 description 2
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 2
- 229940055577 oleyl alcohol Drugs 0.000 description 2
- ZQBAKBUEJOMQEX-UHFFFAOYSA-N phenyl salicylate Chemical compound OC1=CC=CC=C1C(=O)OC1=CC=CC=C1 ZQBAKBUEJOMQEX-UHFFFAOYSA-N 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 239000001509 sodium citrate Substances 0.000 description 2
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 2
- GCLGEJMYGQKIIW-UHFFFAOYSA-H sodium hexametaphosphate Chemical compound [Na]OP1(=O)OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])O1 GCLGEJMYGQKIIW-UHFFFAOYSA-H 0.000 description 2
- 235000019982 sodium hexametaphosphate Nutrition 0.000 description 2
- 239000001540 sodium lactate Substances 0.000 description 2
- 229940005581 sodium lactate Drugs 0.000 description 2
- 235000011088 sodium lactate Nutrition 0.000 description 2
- 229940035044 sorbitan monolaurate Drugs 0.000 description 2
- 239000001593 sorbitan monooleate Substances 0.000 description 2
- 229940035049 sorbitan monooleate Drugs 0.000 description 2
- 239000001577 tetrasodium phosphonato phosphate Substances 0.000 description 2
- 229940042585 tocopherol acetate Drugs 0.000 description 2
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical class OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- SUUWYOYAXFUOLX-ZBRNBAAYSA-N (2s)-2-aminobutanedioic acid;(2s)-2-amino-5-(diaminomethylideneamino)pentanoic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O.OC(=O)[C@@H](N)CCCN=C(N)N SUUWYOYAXFUOLX-ZBRNBAAYSA-N 0.000 description 1
- HOVAGTYPODGVJG-UVSYOFPXSA-N (3s,5r)-2-(hydroxymethyl)-6-methoxyoxane-3,4,5-triol Chemical compound COC1OC(CO)[C@@H](O)C(O)[C@H]1O HOVAGTYPODGVJG-UVSYOFPXSA-N 0.000 description 1
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Chemical compound FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- BFPYWIDHMRZLRN-UHFFFAOYSA-N 17alpha-ethynyl estradiol Natural products OC1=CC=C2C3CCC(C)(C(CC4)(O)C#C)C4C3CCC2=C1 BFPYWIDHMRZLRN-UHFFFAOYSA-N 0.000 description 1
- LRZBIPQJHILPJI-UHFFFAOYSA-N 2,3-dihydroxypropyl 2-(2,3-dihydroxypropyl)octadecanoate Chemical compound CCCCCCCCCCCCCCCCC(CC(O)CO)C(=O)OCC(O)CO LRZBIPQJHILPJI-UHFFFAOYSA-N 0.000 description 1
- JPWUIQIFCDAWQX-UHFFFAOYSA-N 2,3-dihydroxypropyl 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OCC(O)CO JPWUIQIFCDAWQX-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- RZRNAYUHWVFMIP-GDCKJWNLSA-N 3-oleoyl-sn-glycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@H](O)CO RZRNAYUHWVFMIP-GDCKJWNLSA-N 0.000 description 1
- XZIIFPSPUDAGJM-UHFFFAOYSA-N 6-chloro-2-n,2-n-diethylpyrimidine-2,4-diamine Chemical compound CCN(CC)C1=NC(N)=CC(Cl)=N1 XZIIFPSPUDAGJM-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- USURYVONRGTVIF-AMQKJUDNSA-N Dihydroxycholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C(O)O)[C@@]1(C)CC2 USURYVONRGTVIF-AMQKJUDNSA-N 0.000 description 1
- BFPYWIDHMRZLRN-SLHNCBLASA-N Ethinyl estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 BFPYWIDHMRZLRN-SLHNCBLASA-N 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 1
- 241000208690 Hamamelis Species 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 1
- 240000000912 Macadamia tetraphylla Species 0.000 description 1
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 241000772415 Neovison vison Species 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- PDMMFKSKQVNJMI-BLQWBTBKSA-N Testosterone propionate Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](OC(=O)CC)[C@@]1(C)CC2 PDMMFKSKQVNJMI-BLQWBTBKSA-N 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- NCHJGQKLPRTMAO-XWVZOOPGSA-N [(2R)-2-[(2R,3R,4S)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O NCHJGQKLPRTMAO-XWVZOOPGSA-N 0.000 description 1
- DRRMRHKHTQRWMB-UHFFFAOYSA-N [3-(2-ethylhexanoyloxy)-2,2-bis(2-ethylhexanoyloxymethyl)propyl] 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OCC(COC(=O)C(CC)CCCC)(COC(=O)C(CC)CCCC)COC(=O)C(CC)CCCC DRRMRHKHTQRWMB-UHFFFAOYSA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 229960004050 aminobenzoic acid Drugs 0.000 description 1
- ALYNCZNDIQEVRV-UHFFFAOYSA-N aniline-p-carboxylic acid Natural products NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 229960002223 arginine aspartate Drugs 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- RWCCWEUUXYIKHB-UHFFFAOYSA-N benzophenone Chemical compound C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 description 1
- 239000012965 benzophenone Substances 0.000 description 1
- WERYXYBDKMZEQL-UHFFFAOYSA-N butane-1,4-diol Chemical compound OCCCCO WERYXYBDKMZEQL-UHFFFAOYSA-N 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 229940105990 diglycerin Drugs 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- KPUWHANPEXNPJT-UHFFFAOYSA-N disiloxane Chemical class [SiH3]O[SiH3] KPUWHANPEXNPJT-UHFFFAOYSA-N 0.000 description 1
- PXEDJBXQKAGXNJ-QTNFYWBSSA-L disodium L-glutamate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](N)CCC([O-])=O PXEDJBXQKAGXNJ-QTNFYWBSSA-L 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- 229960002568 ethinylestradiol Drugs 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 235000008524 evening primrose extract Nutrition 0.000 description 1
- 239000010475 evening primrose oil Substances 0.000 description 1
- 229940089020 evening primrose oil Drugs 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 229940072117 fennel extract Drugs 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- FODTZLFLDFKIQH-FSVGXZBPSA-N gamma-Oryzanol (TN) Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)O[C@@H]2C([C@@H]3CC[C@H]4[C@]5(C)CC[C@@H]([C@@]5(C)CC[C@@]54C[C@@]53CC2)[C@H](C)CCC=C(C)C)(C)C)=C1 FODTZLFLDFKIQH-FSVGXZBPSA-N 0.000 description 1
- GDSRMADSINPKSL-HSEONFRVSA-N gamma-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO GDSRMADSINPKSL-HSEONFRVSA-N 0.000 description 1
- 229940080345 gamma-cyclodextrin Drugs 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 229960005150 glycerol Drugs 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- HOVAGTYPODGVJG-UHFFFAOYSA-N methyl beta-galactoside Natural products COC1OC(CO)C(O)C(O)C1O HOVAGTYPODGVJG-UHFFFAOYSA-N 0.000 description 1
- LAQFLZHBVPULPL-UHFFFAOYSA-N methyl(phenyl)silicon Chemical compound C[Si]C1=CC=CC=C1 LAQFLZHBVPULPL-UHFFFAOYSA-N 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- RZRNAYUHWVFMIP-UHFFFAOYSA-N monoelaidin Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-UHFFFAOYSA-N 0.000 description 1
- 235000013923 monosodium glutamate Nutrition 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- 229940117969 neopentyl glycol Drugs 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- 229940060184 oil ingredients Drugs 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 125000001820 oxy group Chemical group [*:1]O[*:2] 0.000 description 1
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 1
- 229940094443 oxytocics prostaglandins Drugs 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 229960000969 phenyl salicylate Drugs 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229940068886 polyethylene glycol 300 Drugs 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 150000003180 prostaglandins Chemical class 0.000 description 1
- DCBSHORRWZKAKO-UHFFFAOYSA-N rac-1-monomyristoylglycerol Chemical compound CCCCCCCCCCCCCC(=O)OCC(O)CO DCBSHORRWZKAKO-UHFFFAOYSA-N 0.000 description 1
- 229930002330 retinoic acid Natural products 0.000 description 1
- 235000011083 sodium citrates Nutrition 0.000 description 1
- 229940073490 sodium glutamate Drugs 0.000 description 1
- 230000007928 solubilization Effects 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 235000011069 sorbitan monooleate Nutrition 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000012798 spherical particle Substances 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 229960001712 testosterone propionate Drugs 0.000 description 1
- IETSNGDRGBQDKY-UHFFFAOYSA-N tetracosan-12-ol Chemical compound CCCCCCCCCCCCC(O)CCCCCCCCCCC IETSNGDRGBQDKY-UHFFFAOYSA-N 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- ODLHGICHYURWBS-LKONHMLTSA-N trappsol cyclo Chemical compound CC(O)COC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)COCC(O)C)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1COCC(C)O ODLHGICHYURWBS-LKONHMLTSA-N 0.000 description 1
- VLPFTAMPNXLGLX-UHFFFAOYSA-N trioctanoin Chemical compound CCCCCCCC(=O)OCC(OC(=O)CCCCCCC)COC(=O)CCCCCCC VLPFTAMPNXLGLX-UHFFFAOYSA-N 0.000 description 1
- 229940005605 valeric acid Drugs 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
Landscapes
- Cosmetics (AREA)
- Fats And Perfumes (AREA)
Abstract
Description
【0001】[0001]
【産業上の利用分野】本発明は香料分離や油浮きがなく
安定性良好で、スキンケア感覚の付与された使用感に優
れたボディー用コロンに関する。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a colon for a body which is free from fragrance separation and oil floating and has good stability, and which is imparted with a skin care feeling and is excellent in usability.
【0002】[0002]
【従来の技術】従来のボディー用コロンとは、エタノー
ルに香料を配合したものが主流であるが、これらの製品
はさっぱりとした使用感を有するものの、肌を健やかに
保つためのエモリエント効果等に欠けている。 近年こ
れらのコロンの中で、日常的な使用を目的としてライト
な感覚で使用でき、しかもエモリエント効果や美肌の効
果も得られ、香りが楽しめるスキンケア感覚をうたう製
品のニーズが高まってきた。即ちエタノール=香料系の
従来のコロンに多少の水、保湿剤、油分等が配合され、
エタノール溶媒系のコロンより保湿性が高くなったもの
である。2. Description of the Related Art Conventional colons for bodies are mainly ethanol blended with a fragrance. Although these products have a refreshing feeling, they have an emollient effect for keeping skin healthy. Missing. In recent years, there has been an increasing need for products that can be used in a light sense for daily use in these colognes, and also have an emollient effect and a beautiful skin effect, and give a scent- enjoyable skin care feeling. That is, ethanol = fragrance-based conventional colon with some water, moisturizer, oil, etc.
It is more moisturizing than the ethanol solvent system colon.
【0003】しかしながら、ここで従来のコロンタイプ
に単に水を添加すると香料が分離して(香料浮き)安定
性が悪くなる。安定なコロンとする為には、アルコール
高濃度水溶液に溶解する香料を配合することによって安
定性を改善することはできるが、この方法では香料種が
限られるため香りの幅がせまくなり、フレグランスとし
ての広がりがなくなってしまい、安定性の上でも十分で
はない。又、香りにこく・重厚感を持たせようとする
と、配合する精油(香料成分)が炭化水素系あるいは分
子量の高い成分になるので、アルコール水溶液に溶解し
なくなり、安定性が悪くなる。このような系の安定性を
持たせる為には、低温で濾過して、沈澱物を取り去ると
いう工程を加えるが、十分な経日安定性を確保すること
はできなかった。However, if water is simply added to the conventional colon type here, the fragrance is separated (floating fragrance) and the stability deteriorates. In order to make a stable colon, it is possible to improve the stability by blending a fragrance that is dissolved in a highly concentrated alcoholic solution, but this method limits the fragrance species, which narrows the width of the fragrance and creates a fragrance. Is no longer sufficient, and stability is not sufficient. In addition, if an attempt is made to give the scent a rich and profound feeling, since the essential oil (perfume ingredient) to be blended becomes a hydrocarbon type or a component having a high molecular weight, it will not dissolve in the alcohol aqueous solution and the stability will deteriorate. In order to maintain the stability of such a system, a step of removing the precipitate by filtration at a low temperature is added, but sufficient aging stability could not be secured.
【0004】[0004]
【発明が解決しようとする課題】本発明者らは、このよ
うな事情に鑑み、上記のような香料分離や油浮きなどの
安定性の問題を解決し、肌にやさしく、うるおいをあた
える効果を持つ安定でスキンケア感覚の付与されたボデ
ィー用コロンを得るため鋭意研究を重ねた結果、本発明
を完成するに到った。In view of such circumstances, the present inventors have solved the problems of stability such as the separation of perfume and the floating of oil as described above, and have the effect of giving moisture to the skin and giving moisture. The present invention has been completed as a result of intensive studies to obtain a body colon having a stable and skin-care feeling.
【0005】[0005]
【課題を解決するための手段】本発明の請求項1は、香
料成分を1重量%以上とエタノールと水と界面活性剤と
を配合することを特徴とするボディー用コロン、本発明
の請求項2は、請求項1において、さらに粉末を配合す
ることを特徴とするボディー用コロン、本発明の請求項
3は、請求項2において、さらに塩を配合することを特
徴とするボディー用コロン、本発明の請求項4は、請求
項3において、さらに保湿剤と油分を配合することを特
徴とするボディー用コロンに関する。According to a first aspect of the present invention, there is provided a body colon, which comprises 1% by weight or more of a perfume ingredient, ethanol, water and a surfactant. 2 is a colon for a body in which powder is further added in claim 1, and claim 3 of the present invention is a colon for a body in which a salt is further added in claim 2. A fourth aspect of the invention relates to the body colon according to the third aspect, further comprising a moisturizer and an oil component.
【0006】以下、本発明のボディー用コロンについて
詳述する。本発明で香料や油を安定に配合するために用
いられる界面活性剤は次のものを例示することができ、
それぞれを1種または2種以上適宜選んで用いることが
できる。界面活性剤;ポリオキシエチレン(以下、POE-
と略す)オクチルドデシルアルコール、POE-2-デシルテ
トラデシルアルコールなどのPOE-分岐アルキルエーテ
ル、POE-オレイルアルコールエーテル、POE-セチルアル
コールエーテルなどのPOE-アルキルエーテル、ソルビタ
ンモノオレエート、ソルビタンモノイソステアレート、
ソルビタンモノラウレートなどのソルビタンエステル、
POE-ソルビタンモノオレート、POE-ソルビタンモノイソ
ステアレート、POE-ソルビタンモノラウレートなどのPO
E-ソルビタンエステル、グリセリルモノオレエート、グ
リセリルモノステアレート、グリセリルモノミリステー
トなどのグリセリン脂肪酸エステル、POE-グリセリルモ
ノオレエート、POE-グリセリルモノステアレート、POE-
グリセリルモノミリステートなどのPOE-グリセリン脂肪
酸エステル、POE-ジヒドロコレステロールエーテル、PO
E-硬化ヒマシ油、POE-硬化ヒマシ油イソステアレートな
どのPOE-硬化ヒマシ油脂肪酸エステルなどのPOE-アルキ
ルアリールエーテル、グリセリルイソステアリルエーテ
ル、グリセリルステアリルエーテルなどのグリセリルエ
ーテル、POE-グリセリルイソステアリルエーテル、POE-
グリセリルステアリルエーテルなどのPOE-グリセリルエ
ーテル、ジグリセリルモノステアレート、デカグリセリ
ルデカステアレート、デカグリセリルデカイソステアレ
ート、ジグリセリルジイソステアレートなどのポリグリ
セリン脂肪酸エステルなどの非イオン界面活性剤、α,
β, γ−シクロデキストリン(単独あるいは混合)、ヒ
ドロキシアルキル(メチル、エチル、プロピル、ブチ
ル)シクロデキストリン、ジヒドロキシプロピルシクロ
デキストリン、シクロデキストリンポリマー、マルトシ
ルシクロデキストリン、グルコシルシクロデキストリ
ン、アルキル化(メチル、エチル、プロピル、ブチル)
シクロデキストリン、カルボキシアルキルシクロデキス
トリン、ポリオキシエチレンポリアルキル(C1〜4)
シロキサン等。The body colon of the present invention will be described in detail below. Examples of the surfactant used for stably blending the fragrance and oil in the present invention include the following:
Each of them may be used alone or in combination of two or more. Surfactant: Polyoxyethylene (hereinafter POE-
Abbreviated as) octyldodecyl alcohol, POE-branched alkyl ether such as POE-2-decyltetradecyl alcohol, POE-oleyl alcohol ether, POE-alkyl ether such as POE-cetyl alcohol ether, sorbitan monooleate, sorbitan monoisostea rate,
Sorbitan esters such as sorbitan monolaurate,
POE such as POE-sorbitan monooleate, POE-sorbitan monoisostearate, POE-sorbitan monolaurate
Glycerin fatty acid esters such as E-sorbitan ester, glyceryl monooleate, glyceryl monostearate, glyceryl monomyristate, POE-glyceryl monooleate, POE-glyceryl monostearate, POE-
Glyceryl monomyristate and other POE-glycerin fatty acid esters, POE-dihydrocholesterol ether, PO
E- hydrogenated castor oil, POE- hydrogenated castor oil POE- hydrogenated castor oil such as isostearate POE- alkyl aryl ethers such as fatty acid esters, glyceryl isostearyl ether, glyceryl ethers such as glyceryl stearyl ether, POE- glyceryl isostearyl ether , POE-
Nonionic surfactants such as POE-glyceryl ether such as glyceryl stearyl ether, diglyceryl monostearate, decaglyceryl decasterate, decaglyceryl decaisostearate, polyglycerin fatty acid ester such as diglyceryl diisostearate, α ,
β, γ-cyclodextrin (single or mixed), hydroxyalkyl (methyl, ethyl, propyl, butyl) cyclodextrin, dihydroxypropyl cyclodextrin, cyclodextrin polymer, maltosyl cyclodextrin, glucosyl cyclodextrin, alkylated (methyl, ethyl) , Propyl, butyl)
Cyclodextrin, carboxyalkyl cyclodextrin, polyoxyethylene polyalkyl (C1-4)
Siloxane etc.
【0007】これらの界面活性剤の配合量は0.1%〜
5.0重量%が適当である。0.1%以下では安定性を
良好にするには不十分であり、5%以上では使用時にべ
たつきがでて好ましくない。The blending amount of these surfactants is from 0.1% to
5.0% by weight is suitable. If it is less than 0.1%, it is insufficient to improve the stability, and if it is more than 5%, it is not preferable because it becomes sticky during use.
【0008】本発明において水の配合量は、1重量%〜
30重量%が好ましい。1重量%以下では効果が十分で
なく、30重量%以上では安定化をはかるための界面活
性剤の添加量が増えてコロンとしての使用感が好ましく
なくなる。In the present invention, the blending amount of water is from 1% by weight to.
30% by weight is preferred. If it is less than 1% by weight, the effect is not sufficient, and if it is more than 30% by weight, the amount of the surfactant added for stabilization is increased and the feeling of use as a colon becomes unfavorable.
【0009】本発明に用いられる香料は、動物系、植物
系、鉱物系の天然成分及び合成成分いずれの香料成分で
も使用可能である。香料の配合量は1%〜10重量%が
コロンとして適当であるが、10%以上配合しても問題
はない。The fragrance used in the present invention may be any of fragrance ingredients such as animal-type, plant-type and mineral-type natural ingredients and synthetic ingredients. A proper amount of the fragrance is 1% to 10% by weight as a colon, but there is no problem even if it is added in an amount of 10% or more.
【0010】本発明では、粉末を配合することにより、
さらにべたつきのない使用感に優れたボディー用コロン
を得ることができる。In the present invention, by blending powders,
Furthermore, it is possible to obtain a body colon that is not sticky and has an excellent feeling of use.
【0011】本発明で用いられる粉末は、シリカ、タル
ク、カオリン、雲母チタン、マイカ、ナイロン、シル
ク、セルローズ、ポリエチレン、ポリプロピレンなどで
あり、球状の粒形を有する粉末が好ましい。粉末の配合
量は0.1%〜10重量%が適当である。0.1%以下
ではさらさら感を付与するには十分でなく、10%以上
では粉末の白っぽさが残存する場合がある。The powder used in the present invention is silica, talc, kaolin, titanium mica, mica, nylon, silk, cellulose, polyethylene, polypropylene and the like, and powder having a spherical particle shape is preferable. Appropriate amount of powder is 0.1% to 10% by weight. If it is 0.1% or less, it is not enough to give a silky feel, and if it is 10% or more, the whitishness of the powder may remain.
【0012】又、本発明では、さらに塩を配合すること
により、粉末の凝集のない安定なボディー用コロンを得
ることができる。Further, in the present invention, a stable body colon without aggregation of powder can be obtained by further adding a salt.
【0013】本発明で用いられる塩は、アルカリと酸の
反応物であり、例えば、食塩、乳酸ナトリウム、クエン
酸ナトリウム、ヘキサメタリン酸ソーダ、グルタミン酸
ソーダ、アルギニン−アスパラギン酸塩などである。塩
の配合量は粉末の分散性から0.01%〜5.0重量%
が適当である。The salt used in the present invention is a reaction product of an alkali and an acid, for example, sodium chloride, sodium lactate, sodium citrate, sodium hexametaphosphate, sodium glutamate, arginine-aspartate and the like. The blending amount of salt is 0.01% to 5.0% by weight from the dispersibility of the powder.
Is appropriate.
【0014】本発明のボディー用コロンには、さらに一
般に用いられる保湿剤、油を配合することによって、さ
らに肌にやさしく、うるおいをあたえるスキンケア感覚
の効果にすぐれたボディー用コロンを得ることができ
る。配合する保湿剤及び油は通常化粧料に用いられる成
分であれば配合でき、油としては極性及び非極性のいず
れのものも使用できるが、例えばマカデミアナッツ油、
月見草油、オリーブ油、ミンク油、ホホバ油、ラノリ
ン、スクワレン等の天然動植物油脂類、流動パラフィ
ン、スクワラン、ワセリン等の炭化水素類、オレイルア
ルコール、ドデシルドデカノール等の高級アルコール
類、イソステアリン酸、オレイン酸、リノレン酸、リノ
ール酸、リノレイン酸、オキシ酸等の高級脂肪酸類、イ
ソプロピルミリステート、ペンタエリスリトール−テト
ラ−2−エチルヘキサノエート、グリセリル−2エチル
ヘキサノエート、ジカプリン酸ネオペンチルグリコール
などのエステル油、メチルフェニルシリコン、ジメチル
シリコン、環状シリコンなどのシリコーン油等が挙げら
れる。なかでも極性油、シリコン油が好ましく、その配
合量は、0.1〜5重量%が好ましい。The body cologne of the present invention may further contain a moisturizer and an oil that are generally used to obtain a body cologne that is more gentle to the skin and is excellent in the effect of skin care to give moisture. The humectant and oil to be blended can be blended as long as they are components usually used in cosmetics, and both polar and non-polar oils can be used, for example macadamia nut oil,
Evening primrose oil, olive oil, mink oil, jojoba oil, lanolin, squalene and other natural animal and vegetable oils, liquid paraffin, squalane, hydrocarbons such as vaseline, higher alcohols such as oleyl alcohol and dodecyldodecanol, isostearic acid, oleic acid Higher fatty acids such as linolenic acid, linoleic acid, linoleic acid and oxy acid, isopropyl myristate, pentaerythritol-tetra-2-ethylhexanoate, glyceryl-2ethylhexanoate, dicapric acid neopentylglycol ester Examples thereof include oils, silicone oils such as methylphenyl silicone, dimethyl silicone, and cyclic silicone. Of these, polar oil and silicone oil are preferable, and the compounding amount thereof is preferably 0.1 to 5% by weight.
【0015】保湿剤としては、グリセリン、ジグリセリ
ン、1,3ブチレングリコール、1,4ブチレングリコ
ール、ジプロピレングリコール、プロピレングリコー
ル、ポリエチレングリコール300、400、150
0、6000、マルチトール、ソルビトール、マンノー
ス、ガラクトース、ポリオキシエチレンメチルグルコシ
ド等が用いられ、配合量としては、0.5重量%〜10
重量%が好ましい。As the moisturizer, glycerin, diglycerin, 1,3 butylene glycol, 1,4 butylene glycol, dipropylene glycol, propylene glycol, polyethylene glycol 300, 400, 150
0,6000, maltitol, sorbitol, mannose, galactose, polyoxyethylene methyl glucoside, etc. are used, and the compounding amount is 0.5% by weight to 10%.
Weight percent is preferred.
【0016】本発明のボディー用コロンには、さらにそ
の他薬剤として、ビタミンA、ビタミンD,ビタミン
E,酢酸トコフェロール、アスコルビン酸エステル、ビ
タミンA酸、グリチルレチン酸、レシチン、γ−オリザ
ノール、葉酸等のビタミン類およびビタミン様作用物質
類、エストラジオール、吉草酸エストラジオール、エチ
ニルエストラジオール、プロスタグランジン、プロピオ
ン酸テストステロン等のホルモン類、ベンゾフェノン、
4−t−ブチル−4’−メトキシ−ジベンゾイルメタ
ン、ジメトキシケイ皮酸エチルヘキサン酸グリセリル、
p−アミノ安息香酸エステル、パラメトキシケイ皮酸オ
クチル、サリチル酸フェニル等の紫外線吸収剤類、L−
メントール、カンファー等の消炎剤等を配合することが
できる。又、本発明のボディー用コロンにはその他発明
の効果を損なわない範囲で通常使用される成分を配合す
ることができ、その剤型は乳化系、可溶化系を問わな
い。In the body colon of the present invention, as other drugs, vitamins such as vitamin A, vitamin D, vitamin E, tocopherol acetate, ascorbic acid ester, vitamin A acid, glycyrrhetinic acid, lecithin, γ-oryzanol and folic acid. And vitamin-like acting substances, estradiol, valeric acid estradiol, ethinyl estradiol, prostaglandins, hormones such as testosterone propionate, benzophenone,
4-t-butyl-4′-methoxy-dibenzoylmethane, dimethoxycinnamic acid ethylhexanoate glyceryl,
UV absorbers such as p-aminobenzoic acid ester, octyl paramethoxycinnamate, phenyl salicylate, L-
Anti-inflammatory agents such as menthol and camphor can be added. In addition, the body colon of the present invention may be blended with other commonly used components within the range that does not impair the effects of the present invention, and its formulation may be either an emulsion system or a solubilization system.
【0017】[0017]
【発明の効果】本発明のボディー用コロンは、日常的な
使用を目的としてライトな感覚で使用でき、しかもエモ
リエント効果や美肌の効果も得られ香りが楽しめるとい
ったスキンケア感覚の付与された、香料分離や油浮きの
ない安定性に優れたボディ−用コロンである。EFFECTS OF THE INVENTION The cologne for body of the present invention can be used in a light sensation for daily use, and has a skin care sensation such that an emollient effect and a beautiful skin effect can be obtained and the scent can be enjoyed. It is a colon for body with excellent stability and no oil floating.
【0018】[0018]
【実施例】次に実施例によって本発明をさらに詳細に説
明する。本発明はこれにより限定されるものではない。
配合量は重量%である。The present invention will be described in more detail with reference to the following examples. The present invention is not limited to this.
The blending amount is% by weight.
【0019】尚、使用性については、専門パネル10名
により、使用中、使用後のさらさら感を下記基準に基づ
いて採点評価し、平均値から総合評価した。 大変良い +2、 良い +1、やや悪い −1、悪い
−2、 平均値 1以上2以下・・・◎、0以上1未満・・・
○、−1以上0未満・・・△、−2以上−1未満・・・
×As for usability, ten expert panels scored and evaluated the dry feeling during use and after use based on the following criteria, and comprehensively evaluated from the average value. Very good +2, good +1, somewhat bad -1, bad -2, average value 1 or more and 2 or less ... ◎, 0 or more and less than 1 ...
○, -1 or more and less than 0 ... △, -2 or more and less than -1 ...
×
【0020】安定性試験は、各試料を0℃、RT(室
温)、37℃、50℃の温度条件下で1か月間保存した
後の状態を評価した。 油浮き、香料浮きが無く安定である・・・○ 油浮き、香料浮きがみられる・・・・・・×In the stability test, each sample was evaluated for its condition after being stored under the temperature conditions of 0 ° C., RT (room temperature), 37 ° C. and 50 ° C. for one month. Stable with no oil scents and fragrances ... ○ Oil scents and fragrances are observed ...
【0021】再分散性については、試料を入れた瓶を上
下に5回振った時の粉末の分散の程度を観察し評価し
た。 粉末が均一に再分散する・・・○ 再分散性が悪い・・・・・・・×The redispersibility was evaluated by observing the degree of dispersion of the powder when the bottle containing the sample was shaken up and down 5 times. The powder redisperses uniformly ... ○ Poor redispersibility ...
【0022】表1に実施例1,2と比較例1〜3を評価
結果と共に示す。製法は実施例、比較例ともエタノール
に香料、界面活性剤、油を溶かし、これに精製水に食塩
を溶かし、粉末をホモミキサー分散処理したパートを添
加する方法で行った。Table 1 shows Examples 1 and 2 and Comparative Examples 1 to 3 together with the evaluation results. In each of the Examples and Comparative Examples, the manufacturing method was a method in which a flavor, a surfactant, and an oil were dissolved in ethanol, salt was dissolved in purified water, and a part obtained by dispersing the powder in a homomixer was added.
【0023】[0023]
【表1】 [Table 1]
【0024】実施例1はスキンケア感覚として水を配合
し、実施例2は水と油を配合したものであるが、界面活
性剤と食塩の添加により、安定性も使用性も良好な粉末
入りボディーコロンが得られる。一方、比較例1は界面
活性剤と食塩・粉末が配合されていないので、安定性が
悪かった。比較例2は食塩が配合されていないで、粉末
の再分散性が悪かった。In Example 1, water was blended as a skin care sensation, and in Example 2 water and oil were blended. With the addition of a surfactant and salt, a powdered body having good stability and usability. You get a colon. On the other hand, Comparative Example 1 was poor in stability because the surfactant and the salt / powder were not mixed. In Comparative Example 2, no salt was blended, and the redispersibility of the powder was poor.
【0025】 実施例4 コロン (重量%) (A)エタノール 77.4 香料 1.0 イソプロピルミリステート 0.5 POE(30モル)ジヒドロキシ コレステロールエーテル 2.0 ジグリセリンジイソステアレート 0.5 2−ヒドロキシ4−メトキシベンゾフェノン 0.1 (B)精製水 5.0 食塩 0.5 グリセリン 1.0 球状セルロース粉末 10.0 (製法)Aのアルコール部を均一に溶解し、Bの水相部
をホモミキサー分散処理した後、AにBを加えて混合し
粉末入りボディーコロンを得た。Example 4 Colon (% by weight) (A) Ethanol 77.4 Perfume 1.0 Isopropyl myristate 0.5 POE (30 mol) Dihydroxy cholesterol ether 2.0 Diglycerin diisostearate 0.5 2- Hydroxy 4-methoxybenzophenone 0.1 (B) Purified water 5.0 Salt 0.5 Glycerin 1.0 Spherical cellulose powder 10.0 (Production method) The alcohol part of A is uniformly dissolved, and the aqueous phase part of B is homogenized. After the mixer dispersion treatment, B was added to A and mixed to obtain a powder-containing body colon.
【0026】 実施例5 (重量%) (A)エタノール 64.23 香料 2.0 トリオクタン酸グリセリル 3.0 ビタミンEアセテート 0.02 POE(60)硬化ヒマシ油誘導体 1.0 ジグリセリンジイソステアレート 0.5 (B)精製水 28.0 クエン酸ナトリウム 0.05 球状ポリエチレン粉末 1.0 ウイキョウエキス 0.1 ハマメリス抽出液 0.1 (製法)Aのアルコール部を均一に溶解し、Bの水相部
をホモミキサー分散処理した後、AにBを加えて混合し
粉末入りボディーコロンを得た。Example 5 (wt%) (A) Ethanol 64.23 Fragrance 2.0 Glyceryl trioctanoate 3.0 Vitamin E acetate 0.02 POE (60) hydrogenated castor oil derivative 1.0 Diglycerin diisostearate 0.5 (B) Purified water 28.0 Sodium citrate 0.05 Spherical polyethylene powder 1.0 Fennel extract 0.1 Hamamelis extract 0.1 (Manufacturing method) The alcohol part of A is uniformly dissolved, and the water of B is dissolved. After the phase portion was subjected to a homomixer dispersion treatment, B was added to A and mixed to obtain a powder-containing body colon.
【0027】 実施例6 (重量%) (A)エタノール 69.94 香料 1.0 (B)精製水 20.0 ヒドロキシプロピル−β−シクロデキストリン 5.0 グリチルリチン酸ジカリウム 0.05 ヘキサメタリン酸ソーダ 0.01 セルロース粉末 0.1 1,3ブチレングリコール 3.0 (製法)Aのアルコール部を均一に溶解し、Bの水相部
を溶解後ホモミキサー分散処理して、AにBを加えて混
合し粉末入りボディーコロンを得た。Example 6 (% by weight) (A) Ethanol 69.94 Fragrance 1.0 (B) Purified water 20.0 Hydroxypropyl-β-cyclodextrin 5.0 Dipotassium glycyrrhizinate 0.05 Sodium hexametaphosphate 0. 01 Cellulose powder 0.1 1,3 Butylene glycol 3.0 (Production method) The alcohol part of A was uniformly dissolved, and the aqueous phase part of B was dissolved and homomixer-dispersed, and B was added to A and mixed. A body colon containing powder was obtained.
【0028】 実施例7 (重量%) (A)エタノール 80.7 香料 7.0 メチルポリシロキサン 0.1 ジメチルポリシロキサンポリエチレングリコール 0.1 (B)精製水 5.0 乳酸ナトリウム(50%液) 5.0 球状シリカ 0.1 1,3ブチレングリコール 2.0 (製法)Aのエタノール部とBの粉末部をそれぞれ均一
に溶解分散した後、AにBを加えて混合し粉末入りコロ
ンを得た。Example 7 (% by weight) (A) Ethanol 80.7 Fragrance 7.0 Methyl polysiloxane 0.1 Dimethyl polysiloxane polyethylene glycol 0.1 (B) Purified water 5.0 Sodium lactate (50% liquid) 5.0 Spherical silica 0.1 1,3 Butylene glycol 2.0 (Production method) The ethanol part of A and the powder part of B were uniformly dissolved and dispersed, and then B was added to A and mixed to obtain a colon containing powder. It was
【0029】実施例4〜7はいずれも安定性良好で、さ
らさらした使用感触をもちスキンケア感覚を有するボデ
ィー用コロンであった。All of Examples 4 to 7 were colons for the body which had good stability and had a dry feel and a skin care feeling.
Claims (4)
と界面活性剤とを配合することを特徴とするボディー用
コロン。1. A body colon, comprising 1% by weight or more of a fragrance component, ethanol, water and a surfactant.
ことを特徴とするボディー用コロン。2. A body colon according to claim 1, further comprising powder.
とを特徴とするボディー用コロン。3. The body colon according to claim 2, further comprising a salt.
配合することを特徴とするボディー用コロン。4. The colon for body according to claim 3, further comprising a moisturizer and an oil component.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP10603292A JPH05279236A (en) | 1992-03-31 | 1992-03-31 | Cologne for body |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP10603292A JPH05279236A (en) | 1992-03-31 | 1992-03-31 | Cologne for body |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH05279236A true JPH05279236A (en) | 1993-10-26 |
Family
ID=14423301
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP10603292A Pending JPH05279236A (en) | 1992-03-31 | 1992-03-31 | Cologne for body |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH05279236A (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2756487A1 (en) * | 1996-12-03 | 1998-06-05 | Fabre Pierre Dermo Cosmetique | New cosmetic composition comprising micronised cyclodextrin and mica |
| EP0978273A1 (en) * | 1998-08-04 | 2000-02-09 | Shiseido Company Limited | Beauty method |
| JP2003095906A (en) * | 2001-09-27 | 2003-04-03 | Lion Corp | Antiperspirant deodorant composition |
| WO2016075328A1 (en) * | 2014-11-14 | 2016-05-19 | Antonio Puig, S.A. | Long lasting fragrance composition |
| JP2016150902A (en) * | 2015-02-16 | 2016-08-22 | 株式会社グローバル プロダクト プランニング | Flavor containing sheet and method for producing the same |
| CN110022983A (en) * | 2016-12-14 | 2019-07-16 | 埃科莱布美国股份有限公司 | Functionalized siloxanes for froth flotation |
-
1992
- 1992-03-31 JP JP10603292A patent/JPH05279236A/en active Pending
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2756487A1 (en) * | 1996-12-03 | 1998-06-05 | Fabre Pierre Dermo Cosmetique | New cosmetic composition comprising micronised cyclodextrin and mica |
| EP0978273A1 (en) * | 1998-08-04 | 2000-02-09 | Shiseido Company Limited | Beauty method |
| JP2003095906A (en) * | 2001-09-27 | 2003-04-03 | Lion Corp | Antiperspirant deodorant composition |
| WO2016075328A1 (en) * | 2014-11-14 | 2016-05-19 | Antonio Puig, S.A. | Long lasting fragrance composition |
| JP2016150902A (en) * | 2015-02-16 | 2016-08-22 | 株式会社グローバル プロダクト プランニング | Flavor containing sheet and method for producing the same |
| CN110022983A (en) * | 2016-12-14 | 2019-07-16 | 埃科莱布美国股份有限公司 | Functionalized siloxanes for froth flotation |
| CN110022983B (en) * | 2016-12-14 | 2022-03-01 | 埃科莱布美国股份有限公司 | Functionalized siloxanes for froth flotation |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI395596B (en) | Emulsion composition | |
| KR20170031711A (en) | Starting material for cosmetics | |
| EP1641904A2 (en) | O/w emulsifier, o/w emulsion and applications thereof | |
| JPWO2018105040A1 (en) | Oil-in-water emulsified cosmetic | |
| JPWO2006028012A1 (en) | Cosmetics and method for producing the same | |
| JP2004161775A (en) | Cosmetic and dermatological preparations containing vitamin F, complexes and mixtures comprising cyclodextrin and required fatty acids, and process for producing said preparations | |
| JP5492555B2 (en) | Vesicle-containing composition and method for producing the same | |
| JPH05279236A (en) | Cologne for body | |
| WO1999065599A1 (en) | Flowable preparations of the water-in-oil emulsion type having an increased water content | |
| JP2002138014A (en) | Fine emulsion composition | |
| JP2015229655A (en) | Topical skin preparation | |
| JP2916689B2 (en) | Cosmetics | |
| EP1083861A1 (en) | Hydrous cosmetic or pharmaceutical sticks | |
| JP3978611B2 (en) | Cosmetic composition | |
| JP2025027473A (en) | Cooling agent composition | |
| JP6395452B2 (en) | Topical skin preparation | |
| JP2011213679A (en) | Transparent or translucent composition for external application | |
| JPH08231980A (en) | Perfumary composition | |
| JPH03284611A (en) | Emulsion cosmetic | |
| JPS6138166B2 (en) | ||
| CN112004518A (en) | Aerogels and their use in cosmetic applications | |
| JPH04178316A (en) | Emulsion cosmetic | |
| JP2001354515A (en) | Composite emulsion and cosmetic formulated with the same | |
| JPH01294615A (en) | Two layer type cosmetic | |
| JPH1017434A (en) | Hydrate composition, cosmetic material and composition for lipstick compounded with the same and its production |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20010323 |